Martin Štěrba
6PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 08, 2021
Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up.Zuzana Pokorná, Petra Kollárová-Brázdová, Olga Lenčová-Popelová
|Sep 23, 2021
Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation.Eduard Jirkovský, Anna Jirkovská, Hana Bavlovič-Piskáčková
|Jul 28, 2021
Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo.Petra Kollárová-Brázdová, Olga Lenčová-Popelová, Galina Karabanovich
|Apr 08, 2020
Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase II<i>β</i> Interaction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity.Petra Kollárová-Brázdová, Anna Jirkovská, Galina Karabanovich
|Aug 15, 2019
<i>In vitro</i> and <i>in vivo</i> investigation of cardiotoxicity associated with anticancer proteasome inhibitors and their combination with anthracycline.Zuzana Pokorna, Eduard Jirkovsky, Marketa Hlavackova
|Jan 10, 2018
Comprehensive review of cardiovascular toxicity of drugs and related agents.Přemysl Mladěnka, Lenka Applová, Jiří Patočka
Pageof 1
Frequent Collaborators
3 joint publications
Petra Štěrbová-Kovaříková
2 joint publications
Veronika Skalická
2 joint publications
Jaroslav Roh
2 joint publications
Jan Kubeš
2 joint publications
Eduard Jirkovský
2 joint publications
Anna Jirkovská
2 joint publications
Galina Karabanovich
2 joint publications
Zuzana Pokorná
2 joint publications
Hana Bavlovič-Piskáčková
1 joint publications
Lenka Applová
